Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Abivax (ABVX) Assets Average (2022 - 2025)

Historic Assets Average for Abivax (ABVX) over the last 3 years, with Q3 2025 value amounting to $448.9 million.

  • Abivax's Assets Average changed N/A to $448.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $448.9 million, marking a year-over-year change of. This contributed to the annual value of $286.5 million for FY2024, which is 3222.95% up from last year.
  • Abivax's Assets Average amounted to $448.9 million in Q3 2025.
  • In the past 5 years, Abivax's Assets Average ranged from a high of $448.9 million in Q3 2025 and a low of $101.0 million during Q4 2022
  • For the 3-year period, Abivax's Assets Average averaged around $223.5 million, with its median value being $197.5 million (2025).
  • Data for Abivax's Assets Average shows a peak YoY increase of 11233.17% (in 2023) and a maximum YoY decrease of 11233.17% (in 2023) over the last 5 years.
  • Abivax's Assets Average (Quarter) stood at $101.0 million in 2022, then surged by 112.33% to $214.5 million in 2023, then skyrocketed by 109.27% to $448.9 million in 2025.
  • Its Assets Average was $448.9 million in Q3 2025, compared to $155.5 million in Q2 2025 and $197.5 million in Q1 2025.